Associate Medical Director, Gynecologic Oncology

Advance patient care in gynecologic oncology as an Associate Medical Director at Natera. In this clinical leadership role, you will direct medical strategy and clinical development for our advanced cell-free DNA (cfDNA) and liquid biopsy portfolio, focusing on minimal residual disease (MRD) and recurrence monitoring for gynecologic malignancies (ovarian, endometrial, cervical, vulvar, and vaginal cancers). You will collaborate across research, development, commercial, and medical affairs teams to ensure the scientific rigor, clinical relevance, and clinical adoption of our molecular testing solutions. Primary Responsibilities: Clinical Development • Partner with the Sr. Medical Director, Oncology on the clinical development of cell-free DNA (cfDNA) molecular diagnostics and liquid biopsy assays for gynecologic cancers. • Direct the development and execution of clinical strategies and evidence-generation plans that demonstrate clinical utility in gynecologic oncology, including minimal residual disease (MRD) tracking, recurrence monitoring, treatment response assessment, and clinical trial enrichment. Medical Education and Communication • Oversee medical education and scientific communications for healthcare providers focused on gynecologic oncology, including tumor boards, webinars, and field medical enablement. • Partner with commercial and marketing teams to deliver clear, data-driven clinical evidence and educational materials to gynecologic oncology stakeholders, including gynecologic oncology surgeons, medical oncologists, pathologists, radiation oncologists, genetic counselors, and advanced practice providers. Representation and Advocacy • Represent Natera at medical congresses and industry events, including SGO, ASCO, and ESMO, both in person and virtually. • Build and maintain relationships with external experts, clinical investigators, cooperative groups such as NRG/GOG, and professional societies within gynecologic oncology. • Maintain a standard of scientific rigor and data-driven urgency across the oncology organization. Research and Development • Collaborate with R&D, biostatistics, clinical operations, and HEOR on protocol development, endpoint selection, data analysis, data interpretation, peer-reviewed publications, and congress submissions in gynecologic oncology. • Support investigator-initiated research, real-world evidence generation, and clinical collaborations that advance the standard of care in gynecologic cancers. Key Skill Sets and Responsibilities: Gynecologic Oncology Expertise • Deep knowledge of gynecologic malignancies, including current treatment paradigms, molecular biomarkers such as HRD, MSI/Lynch, and HPV-related disease, and evolving clinical guidelines. • Provide expert medical guidance on gynecologic oncology clinical use cases, clinical trial design, and complex patient scenarios. Comprehensive Oncology Acumen • Ability to communicate credibly across solid tumor histologies and indications to support cross-portfolio initiatives. • Stay current on advances in oncology and translate data insights into product strategy, clinical evidence, and educational content. Cross-Disciplinary Collaboration • Work effectively with research, development, commercial, medical affairs, regulatory, market access, and legal partners to drive successful product launches and lifecycle management. • Coordinate with internal and external stakeholders to ensure clinical relevance, health-system integration, and clinical adoption of Natera’s oncology solutions. Qualifications: • M.D. or D.O. with board certification in Gynecologic Oncology, or Medical Oncology with a significant gynecologic oncology focus, is required. • Minimum 5 years of post-training experience in oncology with a strong b